Indaptus Therapeutics (INDP) Metrics: History & Chart

Indaptus Therapeutics, Inc.(INDP)

Biotechnology · New York City, NY

$2.57+0.06 (+2.39%)

Delayed quote: Oct 6, 2026, 2:44 PM EDT

About Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials. This candidate is being evaluated for its capacity to elicit lasting therapeutic responses, either as a standalone agent or in combination with other treatments, for various conditions including lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as infections caused by the hepatitis B virus and human immunodeficiency virus. Initially incorporated in 2021 under the name Intec Parent, Inc., the company officially rebranded to Indaptus Therapeutics, Inc. in August of the same year. Its corporate headquarters are situated in New York, New York.

New York City, NY

5 employees

indaptusrx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Junyi Dai

View full financials

Third-Party DCF Estimate (FMP)	$8.30
Price Gap vs Third-Party Estimate	+230.55%

7D Total Return	-23.71%
30D Total Return	+105.75%
YTD Total Return	-13.74%
1Y Total Return	-23.24%
3Y Total Return	-96.58%
5Y Total Return	-98.74%
10Y Total Return	-99.98%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-13.74%
2025	-87.66%
2024	-52.15%
2023	+21.38%
2022	-74.56%
2021	-58.70%
2020

CAGR TTM	-23.14%
CAGR 3Y	-67.53%
CAGR 5Y	-58.32%
CAGR 10Y	-57.48%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

INDP Valuation Metrics

INDP Stock Price Metrics

INDP Dividend Metrics

INDP Growth Rate Metrics

INDP Discounted Cash Flow Metrics

INDP Returns By Period

INDP Yearly Returns

INDP Average Annual Returns By Period (CAGR)

INDP Revenue Metrics

INDP PE Ratio Metrics

INDP PS Ratio Metrics

INDP PB Ratio Metrics

INDP Price to Free Cash Flow Ratio Metrics

INDP Debt to Equity Ratio Metrics

INDP PEG Ratio Metrics

INDP FCF Yield

INDP Earnings Yield

INDP EBITDA Yield

INDP OCF Yield

INDP EV/EBIT Ratio Metrics

INDP EV/EBITDA Ratio Metrics

INDP EV/Assets Ratio Metrics

INDP EV/Sales Ratio Metrics

INDP Current Ratio Metrics

INDP Quick Ratio Metrics

INDP ROIC Metrics

INDP Return on Assets Metrics

INDP Return on Equity Metrics

INDP Net Profit Margin Metrics

INDP Gross Profit Margin Metrics

INDP Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	25.63
PB Ratio Avg TTM	9.78
PB Ratio Avg 3Y	1.43
Current VS TTM Avg	+162.14%
Current VS 3Y Avg	+1693.26%
Current VS 5Y Avg	+2283.44%

PFCF Ratio	2.40
PFCF Ratio Avg TTM	2.44
PFCF Ratio Avg 3Y	2.44
Current VS TTM Avg	-1.82%
Current VS 3Y Avg	-1.82%
Current VS 5Y Avg	-1.82%

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	(0.78)
Debt/Equity Ratio Avg 3Y	0.01
Current VS TTM Avg	+100.00%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	41.65%
FCF Yield Avg TTM	40.55%
FCF Yield Avg 3Y	40.55%
Current VS TTM Avg	+2.72%
Current VS 3Y Avg	+2.72%
Current VS 5Y Avg	+2.72%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	23.69
Ev/Assets Ratio Avg TTM	10.21
Ev/Assets Ratio Avg 3Y	0.41
Current VS TTM Avg	+131.99%
Current VS 3Y Avg	+5665.52%
Current VS 5Y Avg	+6388.47%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	19.48
Current Ratio Avg TTM	5.39
Current Ratio Avg 3Y	3.91
Current VS TTM Avg	+261.21%
Current VS 3Y Avg	+397.90%
Current VS 5Y Avg	+234.87%

Quick Ratio	19.48
Quick Ratio Avg TTM	5.39
Quick Ratio Avg 3Y	3.91
Current VS TTM Avg	+261.21%
Current VS 3Y Avg	+397.90%
Current VS 5Y Avg	+234.87%

ROIC	(129.90%)
ROIC Avg 3Y	(284.73%)
ROIC Avg 5Y	(186.95%)
Current VS 3Y Avg	+54.38%
Current VS 5Y Avg	+30.52%
Current VS 10Y Avg	-1.47%

ROA	(128.66%)
ROA Avg TTM	(67.72%)
ROA Avg 3Y	(51.12%)
Current VS TTM Avg	-90.00%
Current VS 3Y Avg	-151.70%
Current VS 5Y Avg	-308.91%

ROE	(135.62%)
ROE Avg TTM	(387.80%)
ROE Avg 3Y	(279.51%)
Current VS TTM Avg	+65.03%
Current VS 3Y Avg	+51.48%
Current VS 5Y Avg	-6.36%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	+100.00%